Therapeutic Innovations Executive Team’s Strategy Meeting With Investors

The Therapeutic Innovations (TI) executive team was joined by board members Dr. Arthur Coury and Roland Scott, and investor Paul Rogers and his team for a full day meeting to discuss the strategy for bringing the Airbaby to market. 

The session kicked off with introductory presentations from the TI team surrounding the proposed strategy for tackling the problem of infant mortality and comorbidity. The Airbaby intervention was thoroughly discussed and highlighted as an adequate tool for saving infant lives. At certain points throughout the day, the team was joined remotely by various experts to present and chime in on key areas relating to engineering, manufacturing, medical device certification and supply chain. The day concluded with a redefined strategy for the company, and next steps for bringing the intervention to market.